Michael Farrell is the Chief Executive Officer of ResMed Inc., a global leader in the development and provision of innovative medical devices and digital health technologies for the treatment of sleep apnea and other respiratory disorders. Born in Australia, Farrell joined ResMed in 2000 as the General Counsel, leveraging his strong background in law and business. Over the years, he has held various leadership positions within the company, including Senior Vice President of Organizational Development and Global General Counsel, before being appointed CEO in 2013. Under Farrell's leadership, ResMed has experienced significant growth and innovation. He has been instrumental in expanding the company's product portfolio and global reach, particularly through the development of digital health solutions such as the myAir app and the AirSense 10 platform. These advancements have not only improved patient outcomes but also solidified ResMed's position as a market leader in the sleep and respiratory care industry. Farrell's strategic vision has also led to several key acquisitions, including Brightree and MatrixCare, which have enhanced ResMed's capabilities in software and data analytics. As CEO, Michael Farrell continues to drive ResMed's mission of improving the lives of millions of people worldwide. His commitment to innovation, patient-centric care, and corporate responsibility has earned him recognition within the industry and beyond. Farrell's leadership style emphasizes collaboration and empowerment, fostering a culture of continuous improvement and excellence at ResMed. Under his guidance, the company remains at the forefront of addressing global health challenges related to sleep and respiratory disorders.